Cardiovascular regenerative medicine is an emerging field focused on repairing and restoring damaged heart tissues using cutting-edge biological approaches. Stem cell therapy has shown promise in regenerating cardiomyocytes and improving heart function in patients with heart failure or myocardial infarction. Researchers are also exploring the potential of tissue engineering to create bioengineered heart patches for targeted repair. Additionally, advancements in gene editing techniques like CRISPR are being investigated to correct genetic mutations associated with cardiovascular disorders. By combining biomaterials, cellular therapies, and innovative delivery systems, cardiovascular regenerative medicine aims to revolutionize treatment outcomes and offer hope to patients suffering from severe cardiac conditions.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation